# Synapse Labs Pvt. Ltd. – FDA Inspection, Feb 21, 2020

Source: https://www.keypedia.com/records/fda_inspections/synapse-labs-pvt-ltd/e9f74844-00d9-4408-a2fa-9ae8849f2cbd
Source feed: FDA_Inspections

> FDA inspection 1123667 of Synapse Labs Pvt. Ltd., February 21, 2020. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1123667
- Company Name: Synapse Labs Pvt. Ltd.
- Inspection Date: 2020-02-21
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1201266 - 2023-03-09
- FDA Inspection 1036640 - 2017-11-25
- FDA Inspection 1030877 - 2017-08-02

Company: https://www.keypedia.com/companies/synapse-labs-pvt-ltd/8c479822-ed2a-4553-b285-e522198df344

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c